[
    [
        {
            "time": "",
            "original_text": "华大基因：公司生育健康类服务方面涵盖孕前、孕期、新生儿及儿童各阶段",
            "features": {
                "keywords": [
                    "华大基因",
                    "生育健康",
                    "孕前",
                    "孕期",
                    "新生儿",
                    "儿童"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "基因检测"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：公司生育健康类服务方面涵盖孕前、孕期、新生儿及儿童各阶段",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "华大基因：目前公司新冠检测产品可满足不同使用需求及应用场景",
            "features": {
                "keywords": [
                    "华大基因",
                    "新冠检测",
                    "产品",
                    "需求",
                    "应用场景"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "基因检测"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：目前公司新冠检测产品可满足不同使用需求及应用场景",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华大基因：股东和玉高林减持计划的实施不会对公司治理结构及持续经营产生重大影响",
            "features": {
                "keywords": [
                    "华大基因",
                    "股东",
                    "减持计划",
                    "治理结构",
                    "持续经营"
                ],
                "sentiment_score": -0.2,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "基因检测"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华大基因：股东和玉高林减持计划的实施不会对公司治理结构及持续经营产生重大影响",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "华大基因：去年海外业务收入快速增长，在整体业务收入占比首次超60%",
            "features": {
                "keywords": [
                    "华大基因",
                    "海外业务",
                    "收入增长",
                    "占比"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗",
                    "基因检测"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华大基因：去年海外业务收入快速增长，在整体业务收入占比首次超60%",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "医药行业2021年6月投资月报：6月仍然是较好的窗口期 两条思路配置医药",
            "features": {
                "keywords": [
                    "医药行业",
                    "投资月报",
                    "窗口期",
                    "配置思路"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗",
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业2021年6月投资月报：6月仍然是较好的窗口期 两条思路配置医药",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 9,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]